Solidus Labs Unveils Agentic-Based Compliance: A New Model for Trade Surveillance Operations
22.5.2025 15:00:00 EEST | Business Wire | Press release
Solidus Labs, the category-definer in trade surveillance and risk monitoring for digital and traditional asset classes, today announced the launch of Agentic-Based Compliance, a groundbreaking model for surveillance operations that leverages a network of AI agents to deliver exponential efficiency, precision, and intelligence across the entire trade surveillance and transaction monitoring investigation lifecycle.
Legacy compliance solutions have failed to keep up with the rapid modernization and growing complexity of global markets. Compliance teams are forced to work with a patchwork of disconnected and expensive tools that fail to deliver results efficiently. According to McKinsey, compliance analysts spend 80% of their time on low or moderate-risk issues, often repetitively resolving false positives or performing menial work. This inefficiency extends to market abuse detection: Despite the enormous resources and efforts invested in compliance technology, firms continue to face enforcement actions for missed manipulation. Research shows that market abuse like insider trading occurs in 20% of mergers and acquisitions and 5% of quarterly earnings announcements in U.S. markets. More broadly, only 4% of Suspicious Activity Reports (SARs) lead to law enforcement investigations. This isn’t a failure of effort - it’s a failure of architecture.
Built on Solidus’ proprietary platform, HALO, Agentic-Based Compliance reimagines how financial institutions detect, investigate, and resolve market abuse risks. It replaces legacy systems and siloed workflows with a unified, intelligence-led architecture powered by autonomous AI agents that augment human analysts and operate across a multi-dimensional risk environment.
“Agentic-Based Compliance is the only way compliance teams can stay ahead of emerging complexities like 24/7 off-platform trading, enhanced retail participation and the heightened risks they carry for cyber-enhanced financial crimes and cross-product and cross-market manipulation,” said Asaf Meir, Founder and Chief Executive of Solidus Labs. “Our vision is simple: Compliance operations should be as scalable, intelligent, and efficient as the markets they’re designed to protect. Solidus’ Agentic-Based Compliance delivers just that, solving for tech sprawl, alert fatigue, talent shortage and surveillance blind spots that cost firms thousands of hours and can reach billions of dollars in losses and fines.”
HALO embeds a fleet of purpose-built AI agents, each designed to streamline a specific stage of the compliance investigation lifecycle — from signal enrichment and alert remediation to model testing, OSINT intelligence feeds, case management, and regulatory reporting.
Born in crypto’s highly fragmented and complex environment, Solidus’ Agentic-Based Compliance is future-proof by design for all asset classes, leading to 20X faster investigations and saving compliance analysts as much as 5 hours of menial work per day. Like all Solidus Labs’ solutions, it was developed in tandem with regulatory feedback - aligning with the current and evolving demands of modern financial markets, including the imperatives of market abuse regulations in the U.S., EU, and other leading jurisdictions.
Poised to power the next generation of surveillance operations, Solidus’ Agentic-Based Compliance is already gaining traction among forward-looking financial firms seeking to modernize their compliance capabilities and reduce operational strain.
To learn more, visit www.soliduslabs.com.
About Solidus Labs
Solidus Labs is the category-definer for Agentic-Based Compliance in trade surveillance and risk monitoring. Founded in 2018 by Goldman Sachs veterans, the company merges Wall Street rigor, crypto-native innovation, and cybersecurity principles to reinvent compliance for the modern financial era. At the core is HALO, an AI-powered risk-based platform trusted by financial institutions, crypto firms, and regulators globally to drive proactive, intelligence-led oversight — across any product, venue, or asset class.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250522186908/en/
Contacts
Trevor Davis
Gregory FCA for Solidus Labs
443.248.0359
trevor@gregoryfca.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G
Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release
Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als
Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release
Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til
IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release
IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,
DEWA Organises Second Agentic AI Retreat at Al Shera’a, World’s Tallest, Largest and Smartest Net‑Positive Government Building12.6.2026 18:08:00 EEST | Press release
HE Saeed Mohammed Al Tayer, MD & CEO of Dubai Electricity and Water Authority (DEWA),has emphasised that DEWA deploys the latest Agentic AI technologies, in line with the vision to enhance its leading role and reinforce Dubai’s position as the city of the future. He made these remarks during the Agentic AI Executive Retreat DEWA organised at Al Shera’a, its new headquarters, which is the world’s tallest, largest and smartest net-positive government building. The event was attended by the executive leadership team and key stakeholders in digital transformation and artificial intelligence (AI), as well as representatives from SAP and McKinsey. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612633834/en/ DEWA organises second Agentic AI Retreat at Al Shera’a, world’s tallest, largest and smartest net positive government building (Photo: AETOSWire) In his speech, Al Tayer said that DEWA is guided by directives from the wise l
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom